Skip to main content
Log in

A Comparison Between Plastic and Metallic Biliary Stent Placement in Patients Receiving Preoperative Neoadjuvant Chemoradiotherapy for Resectable Pancreatic Cancer

  • Original Scientific Report (including Papers Presented at Surgical Conferences)
  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

The optimal stent type in patients receiving preoperative neoadjuvant chemoradiotherapy (NACRT) is uncertain. The present study aimed to compare the clinical effectiveness of biliary metallic stent (MS) and plastic stent (PS) in patients undergoing preoperative NACRT for resectable pancreatic cancer.

Methods

This retrospective study included 43 patients who required either biliary MS or PS before initiating NACRT for resectable or borderline resectable pancreatic head cancer. Seventeen patients had MS (MS group), while 23 patients had PS (PS group). All patients received preoperative NACRT, including gemcitabine and concomitant three-dimensional radiation of 54 Gy, and underwent pancreatectomy. Stent patency, surgery postponement, postoperative outcomes, and cost-effectiveness were compared between these groups.

Results

There were no significant differences in baseline demographic or tumor characteristics between the groups. Stent patency was significantly longer in the MS group than in the PS group (p = 0.042). There were no differences in time to surgery, intraoperative characteristics, surgical complications, margin positivity, and pathological response between the groups. Furthermore, the medical cost of maintenance of biliary drainage during NACRT was similar between the groups.

Conclusions

MS placement compared to PS in patients receiving preoperative NACRT provided no significant benefits during the postoperative course of pancreatectomy. However, MS placement was associated with long stent patency while showing no economic disadvantage. Therefore, MS placement may be recommended in patients receiving preoperative NACRT for resectable pancreatic cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Traverso LW (2006) Pancreatic cancer: surgery alone is not sufficient. Surg Endosc 20:S446–S449

    Article  PubMed  Google Scholar 

  2. Schnelldorfer T, Ware AL, Sarr MG et al (2008) Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma. Ann Surg 247:456–462

    Article  PubMed  Google Scholar 

  3. Ferrone CR, Brennan MF, Gonen M et al (2008) Pancreatic adenocarcinoma: the actual 5-year survivors. J Gastrointest Surg 12:701–706

    Article  PubMed  Google Scholar 

  4. Chun YS, Milestone BN, Watson JC et al (2010) Defining venous involvement in borderline resectable pancreatic cancer. Ann Surg Oncol 17:2832–2838

    Article  PubMed  Google Scholar 

  5. Laurence JM, Tran PD, Morarji K et al (2011) A systematic review and meta-analysis of survival and surgical outcomes following neoadjuvant chemoradiotherapy for pancreatic cancer. J Gastrointest Surg 15:2059–2069

    Article  PubMed  Google Scholar 

  6. Andriulli A, Festa V, Botteri E et al (2012) Neoadjuvant/preoperative gemcitabine for patients with localized pancreatic cancer: a meta-analysis of prospective studies. Ann Surg Oncol 19:1644–1662

    Article  PubMed  Google Scholar 

  7. Katz MHG, Wang H, Balachandran A et al (2012) Effect of neoadjuvant chemoradiation and surgical technique on recurrence of localized pancreatic cancer. J Gastrointest Surg 16:68–79

    Article  PubMed  Google Scholar 

  8. Papalezova KT, Tyler DS, Blazer DG et al (2012) Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer? J Surg Oncol 106:111–118

    Article  PubMed  Google Scholar 

  9. Niels AVDG, Erik AJR, Casper HJVE et al (2010) Preoperative biliary drainage for cancer of the head of the pancreas. N Engl J Med 362:129–137

    Article  Google Scholar 

  10. Davids PHP, Groen AK, Rauws EAJ et al (1992) Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet 340:1488–1492

    Article  CAS  PubMed  Google Scholar 

  11. Lammer J, Hausegger KA, Flückiger F et al (1996) Common bile duct obstruction due to malignancy: treatment with plastic versus metal stents. Radiology 201:167–172

    Article  CAS  PubMed  Google Scholar 

  12. Soderlund C, Linder S (2006) Covered metal versus plastic stents for malignant common bile duct stenosis: a prospective, randomized, controlled trial. Gastrointest Endosc 63:986–995

    Article  PubMed  Google Scholar 

  13. Isayama H, Yasuda I, Ryozawa S et al (2011) Results of a Japanese multicenter, randomized trial of endoscopic stenting for non-resectable pancreatic head cancer (JM-TEST): covered wallstent versus doublelayer stent. Dig Endosc 23:310–315

    Article  PubMed  Google Scholar 

  14. Moses PL, Alnaamani KM, Barkun AN et al (2013) Randomized trial in malignant biliary obstruction: plastic vs partially covered metal stents. World J Gastroenterol 19:8638–8646

    Article  PubMed  PubMed Central  Google Scholar 

  15. Almadi MA, Barkun A, Martel M (2017) Plastic vs. self-expandable metal stents for palliation in malignant biliary obstruction: a series of meta-analyses. Am J Gastroenterol 112:260–273

    Article  PubMed  Google Scholar 

  16. Wasan SM, Ross WA, Staerkel GA, Lee JH (2005) Use of expandable metallic biliary stents in resectable pancreatic cancer. Am J Gastroenterol 100:2056–2061

    Article  PubMed  Google Scholar 

  17. Mullen JT, Lee JH, Gomez HF et al (2005) Pancreaticoduodenectomy after placement of endobiliary metal stents. J Gastrointest Surg 9:1094–1105

    Article  PubMed  Google Scholar 

  18. Kubota K, Sato T, Watanabe S et al (2014) Covered self-expandable metal stent deployment promises safe neoadjuvant chemoradiation therapy in patients with borderline resectable pancreatic head cancer. Dig Endosc 26:77–86

    Article  PubMed  Google Scholar 

  19. Gardner TB, Spangler CC, Byanova KL et al (2016) Cost-effectiveness and clinical efficacy of biliary stents in patients undergoing neoadjuvant therapy for pancreatic adenocarcinoma in a randomized controlled trial. Gastrointest Endosc 84:460–466

    Article  PubMed  PubMed Central  Google Scholar 

  20. Sho M, Akahori T, Tanaka T et al (2013) Pathological and clinical impact of neoadjuvant chemoradiotherapy using full-dose gemcitabine and concurrent radiation for resectable pancreatic cancer. J Hepatobiliary Pancreat Sci 20:197–205

    Article  PubMed  Google Scholar 

  21. Sho M, Akahori T, Tanaka T et al (2015) Optimal indication of neoadjuvant chemoradiotherapy for pancreatic cancer. Langenbeck’s Arch Surg 400:477–485

    Article  Google Scholar 

  22. Sobin LH, Gospodarowicz MK, Wittekind C (2009) TNM classification of malignant tumours, 7th edn. Wiley-Liss, New York

    Google Scholar 

  23. Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17:1471–1474

    Article  PubMed  Google Scholar 

  24. Dindo D, Demartines N, Clavien P-A (2004) Classification of surgical complications. Ann Surg 240:205–213

    Article  PubMed  PubMed Central  Google Scholar 

  25. Bassi C, Dervenis C, Butturini G et al (2005) Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 138:8–13

    Article  PubMed  Google Scholar 

  26. Wente MN, Veit JA, Bassi C et al (2007) Postpancreatectomy hemorrhage (PPH)-an international study group of pancreatic surgery (ISGPS) definition. Surgery 142:20–25

    Article  PubMed  Google Scholar 

  27. Boulay BR, Gardner TB, Gordon SR (2010) Occlusion rate and complications of plastic biliary stent placement in patients undergoing neoadjuvant chemoradiotherapy for pancreatic cancer with malignant biliary obstruction. J Clin Gastroenterol 44:452–455

    CAS  PubMed  Google Scholar 

  28. Aadam AA, Evans DB, Khan A et al (2012) Efficacy and safety of self-expandable metal stents for biliary decompression in patients receiving neoadjuvant therapy for pancreatic cancer: a prospective study. Gastrointest Endosc 76:67–75

    Article  PubMed  Google Scholar 

  29. Tol JA, van Hooft JE, Timmer R et al (2015) Metal or plastic stents for preoperative biliary drainage in resectable pancreatic cancer. Gut 65:1981–1987

    Article  CAS  PubMed  Google Scholar 

  30. Prat F, Chapat O, Ducot B et al (1998) Predictive factors for survival of patients with inoperable malignant distal biliary strictures: a practical management guidelines. Gut 42:76–80

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Prat F, Chapat O, Ducot B et al (1998) A randomized trial of endoscopic drainage methods for inoperable malignant strictures of the common bile duct. Gastrointest Endosc 47:1–7

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Masayuki Sho.

Ethics declarations

Conflict of interest

Authors Nakamura, Sho, Akahori, Nagai, Nishiwada, Nakagawa, Tanaka, Kichikawa, Tamamoto, Hasegawa, Mitoro, Yoshiji, and Ikeda have no conflicts of interest or financial ties to disclose.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nakamura, K., Sho, M., Akahori, T. et al. A Comparison Between Plastic and Metallic Biliary Stent Placement in Patients Receiving Preoperative Neoadjuvant Chemoradiotherapy for Resectable Pancreatic Cancer. World J Surg 43, 642–648 (2019). https://doi.org/10.1007/s00268-018-4820-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-018-4820-6

Navigation